InsiderTrades

Form 4 for MRSH Marsh McLennan

Accepted 2026-09-03 16:01:12 ET · period of report 2026-09-02 · accession 0000062709-26-000228 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2026-09-03 16:01 2026-09-02 MRSH Doyle John Q Pres, CEO M - OptEx $73.19 +16.7K 133.5K +14% +$1.22M
DT 2026-09-03 16:01 2026-09-02 MRSH Doyle John Q Pres, CEO S - Sale+OE $188.51 -16.7K 116.8K -12% -$3.14M
DT 2026-09-03 16:01 2026-09-02 MRSH Doyle John Q Pres, CEO M - OptEx $0.00 -16.7K 16.7K -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-09-02 M A 16,656 $73.19 133,467.02 D — — (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
2 Common Common Stock 2026-09-02 S D 16,656 $188.51 116,811.02 D — — (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
3 Derivative Stock Options (Right to Buy) 2026-09-02 M D 16,656 $0.00 16,656 D $73.19 · — to 2027-02-21 16,656 Common Stock (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. (F2) These options were granted on February 22, 2017 and vested in four equal annual installments on February 22nd of 2018, 2019, 2020 and 2021.